Cyberounds Logo
June 04, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Idiopathic Inflammatory Myopathies: A 2016 Update
CME credit is no longer available for this conference.
Julie J. Paik, M.D.. M.H.S. and Lisa Christopher-Stine, M.D., M.P.H.

Dr. Paik is Assistant Professor of Medicine and Dr. Lisa Christopher-Stine is Associate Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Within the past 12 months, Dr. Paik has been a consultant to OctaPharma and NuFactor; Dr. Christopher-Stine has been a scientific advisory board member and a consultant to Mallinckrodt, OctaPharma, Optioncare and Novartis, has done contracted research for CSL Behring and has intellectual property interest on an HMGCR assay licensed to Inova Diagnostics.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose relevant to this activity.

Release Date: 11/15/2016
Termination Date: 11/15/2019

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Distinguish the different forms of myositis based on pattern of weakness, EMG findings, MRI findings and muscle histopathology;
  • List the most common myositis-associated and specific antibodies in polymyositis, dermatomyositis, immune mediated necrotizing myopathy and inclusion body myositis;
  • Recognize that a statin can trigger an immune mediated necrotizing myopathy;
  • Describe the autoantibodies that can characterize specific subgroups of myositis and reveal a specific clinical phenotype associated with the myositis-specific or associated antibody.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity